Supernus Pharmaceuticals
SUPN
#5037
Rank
C$2.48 B
Marketcap
C$42.62
Share price
1.78%
Change (1 day)
-33.26%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2026 (TTM): C-$1.07

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$1.09. In 2025 the company made an earnings per share (EPS) of C-$0.98 a decrease over its 2024 EPS that were of C$1.92.

EPS history for Supernus Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.0710.11%
2025C-$0.98-150.75%
2024C$1.92
2022C$1.6210.78%
2021C$1.46-57.68%
2020C$3.4612.09%
2019C$3.080.47%
2018C$3.0789.38%
2017C$1.62-38.59%
2016C$2.64534.48%
2015C$0.42-211.54%
2014C-$0.37-91.1%
2013C-$4.1939.46%
2012C-$3.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.58-978.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$3.88-455.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.30-4,164.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.48-694.74%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
C$41.03-3,864.47%๐Ÿ‡บ๐Ÿ‡ธ USA